Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.7M Buy
74,257
+72,482
+4,083% +$15.6M 1.53% 40
2026
Q1
$386K Sell
1,775
-20
-1% -$4.44K 0.03% 79
2025
Q4
$410K Buy
1,795
+3
+0.2% +$683 0.04% 74
2025
Q3
$415K Sell
1,792
-43
-2% -$8.76K 0.04% 76
2025
Q2
$341K Sell
1,835
-3
-0.2% -$558 0.03% 86
2025
Q1
$385K Buy
1,838
+78
+4% +$15.2K 0.04% 79
2024
Q4
$313K Hold
1,760
0.03% 90
2024
Q3
$348K Hold
1,760
0.03% 88
2024
Q2
$302K Sell
1,760
-372
-17% -$61.6K 0.03% 97
2024
Q1
$388K Sell
2,132
-80
-4% -$13.8K 0.04% 81
2023
Q4
$343K Buy
2,212
+7
+0.3% +$1.02K 0.04% 85
2023
Q3
$329K Buy
2,205
+540
+32% +$79.3K 0.04% 85
2023
Q2
$224K Hold
1,665
0.03% 103
2023
Q1
$265K Sell
1,665
-211
-11% -$32.3K 0.03% 92
2022
Q4
$303K Buy
+1,876
New +$288K 0.06% 57
2022
Q3
Sell
-1,840
Closed -$282K 90
2022
Q2
$282K Buy
+1,840
New +$281K 0.16% 22
2022
Q1
Sell
-1,475
Closed -$200K 99
2021
Q4
$200K Buy
+1,475
New +$174K 0.06% 35
2021
Q3
Sell
-1,475
Closed -$166K 94
2021
Q2
$166K Buy
+1,475
New +$166K 0.1% 27

Other funds holding ABBV

Godsey & Gibb Inc's ABBV Position: Q2 2026 in Review

Godsey & Gibb Inc increased its AbbVie (ABBV) stake by 4,083% in Q2 2026, buying an estimated $15.6M and bringing the position to 74,257 shares worth $18.7M. The position accounts for 1.53% of the portfolio, ranked #40.

Godsey & Gibb Inc first reported a position in ABBV in Q2 2021 and has held it in 18 quarters since. 1,602 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Godsey & Gibb Inc held 74,257 shares of AbbVie worth $18.7M as of Q2 2026.
  • Godsey & Gibb Inc bought 72,482 AbbVie shares in Q2 2026, an estimated $15.6M.
  • AbbVie made up 1.53% of Godsey & Gibb Inc's portfolio in Q2 2026, its #40 holding.
  • Godsey & Gibb Inc first reported a position in AbbVie in Q2 2021 and has held it in 18 quarters since.
  • 1,602 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Godsey & Gibb Inc's 13F filing for Q2 2026, filed 13 Jul 2026.